Price loading...

The 2023-2028 Outlook for HIV and AIDS Therapeutics in the United States

Price data last checked 102 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
26 October 2022
Listed Since
10 November 2022

Similar Products You Might Like

The 2023-2028 Outlook for HIV-AIDS Testing in the United States
98% match

The 2023-2028 Outlook for HIV-AIDS Testing in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for HIV and AIDS Therapeutics in India
98% match

The 2023-2028 Outlook for HIV and AIDS Therapeutics in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Blood Test in HIV Self-Testing in the United States
97% match

The 2023-2028 Outlook for Blood Test in HIV Self-Testing in the United States

£520.00 14 Jan 2026
The 2023-2028 Outlook for Antiviral Drugs in the United States
97% match

The 2023-2028 Outlook for Antiviral Drugs in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States
97% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in the United States

£520.00 14 Jan 2026
The 2023-2028 World Outlook for HIV-AIDS Confirmatory Tests
97% match

The 2023-2028 World Outlook for HIV-AIDS Confirmatory Tests

£795.00 08 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States
97% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies in the United States

£520.00 07 Feb 2026
The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Inflammatory Lupus Drugs in the United States

£520.00 28 Jan 2026
The 2023-2028 Outlook for Therapeutic Drug Monitoring in the United States
96% match

The 2023-2028 Outlook for Therapeutic Drug Monitoring in the United States

£520.00 22 Jan 2026
The 2023-2028 Outlook for Insomnia Therapeutics in the United States
96% match

The 2023-2028 Outlook for Insomnia Therapeutics in the United States

£520.00 15 Jan 2026
The 2023-2028 Outlook for Sarcopenia Treatments in the United States
96% match

The 2023-2028 Outlook for Sarcopenia Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Topical Vitiligo Therapeutics in the United States
96% match

The 2023-2028 Outlook for Topical Vitiligo Therapeutics in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States
96% match

The 2023-2028 Outlook for Gonorrhea Therapeutics in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Anti-Malarial Drugs in the United States
96% match

The 2023-2028 Outlook for Anti-Malarial Drugs in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Viral Infections in the United States
96% match

The 2023-2028 Outlook for Viral Infections in the United States

£520.00 23 Jan 2026
The 2023-2028 Outlook for Intravenous Therapy and Vein Access in the United States
96% match

The 2023-2028 Outlook for Intravenous Therapy and Vein Access in the United States

£520.00 29 Jan 2026
The 2023-2028 Outlook for Hydroxychloroquine Sulphates in the United States
96% match

The 2023-2028 Outlook for Hydroxychloroquine Sulphates in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Over the Counter Drugs in the United States
96% match

The 2023-2028 Outlook for Over the Counter Drugs in the United States

£520.00 10 Dec 2025
The 2023-2028 Outlook for Autism Spectrum Disorder Therapeutics in the United States
96% match

The 2023-2028 Outlook for Autism Spectrum Disorder Therapeutics in the United States

£520.00 12 Jan 2026
The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States
96% match

The 2023-2028 Outlook for Alpha-1 Antitrypsin Deficiency Treatments in the United States

£520.00 05 Feb 2026
The 2023-2028 Outlook for Erythropoietin Drugs in the United States
96% match

The 2023-2028 Outlook for Erythropoietin Drugs in the United States

£520.00 06 Feb 2026
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States
96% match

The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in the United States

£520.00 30 Jan 2026
The 2023-2028 Outlook for Syringes in the United States
96% match

The 2023-2028 Outlook for Syringes in the United States

£520.00 25 Jan 2026
The 2023-2028 Outlook for Kinase Inhibitors in the United States
96% match

The 2023-2028 Outlook for Kinase Inhibitors in the United States

£520.00 10 Jan 2026